PR Newswire | Nov 9, 2021 04:00PM EST

11/09 15:00 CST

Alkermes to Take Part in the Stifel Virtual Healthcare Conference DUBLIN, Nov. 9, 2021

DUBLIN, Nov. 9, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel Virtual Healthcare Conference on Tuesday, Nov. 16, 2021 at 9:20 a.m. ET (2:20 p.m. GMT). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:Alex BraunInvestor Relations+1 781 296 8493

View original content to download multimedia: https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-stifel-virtual-healthcare-conference-301420297.html

SOURCE Alkermes plc